A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

Clinical trial NCT07533708 · RECRUITING

Trial details

NCT number: NCT07533708
Sponsor: Shanghai Henlius Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

mCRPC or Advanced/Metastatic Solid Tumors

Start date: 2026-07-30
Primary completion: 2027-06-29
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.